BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 32951893)

  • 21. Analysis of the effect of adjuvant radiotherapy on outcomes and complications after radical hysterectomy in FIGO stage IB1 cervical cancer patients with intermediate risk factors (GOTIC Study).
    Nakamura K; Kitahara Y; Satoh T; Takei Y; Takano M; Nagao S; Sekiguchi I; Suzuki M
    World J Surg Oncol; 2016 Jun; 14(1):173. PubMed ID: 27356862
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stromal invasion of the cervix can be excluded from the criteria for using adjuvant radiotherapy following radical surgery for patients with cervical cancer.
    Shimada M; Kigawa J; Takahashi M; Minagawa Y; Okada M; Kanamori Y; Itamochi H; Oishi T; Iba T; Terakawa N
    Gynecol Oncol; 2004 Jun; 93(3):628-31. PubMed ID: 15196855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pretreatment proliferation parameters do not add predictive power to clinical factors in cervical cancer treated with definitive radiation therapy.
    Tsang RW; Juvet S; Pintilie M; Hill RP; Wong CS; Milosevic M; Chapman W; Levin W; Manchul LA; Fykes AW
    Clin Cancer Res; 2003 Oct; 9(12):4387-95. PubMed ID: 14555510
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutations of the TP53 gene in adenocarcinoma and squamous cell carcinoma of the cervix: a systematic review.
    Tornesello ML; Buonaguro L; Buonaguro FM
    Gynecol Oncol; 2013 Mar; 128(3):442-8. PubMed ID: 23168175
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association between p53 mutation and clinicopathological features of non-small cell lung cancer.
    Guang SG; Ogura T; Sekine I; Yokozaki M; Esumi H; Kodama T; Nagai K
    Jpn J Clin Oncol; 1997 Aug; 27(4):211-5. PubMed ID: 9379505
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcome and prognostic factors for adenocarcinoma/adenosquamous carcinoma of cervix after definitive radiotherapy.
    Huang YT; Wang CC; Tsai CS; Lai CH; Chang TC; Chou HH; Hsueh S; Chen CK; Lee SP; Hong JH
    Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):429-36. PubMed ID: 20542643
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biological and clinical significance of NAC1 expression in cervical carcinomas: a comparative study between squamous cell carcinomas and adenocarcinomas/adenosquamous carcinomas.
    Yeasmin S; Nakayama K; Rahman MT; Rahman M; Ishikawa M; Katagiri A; Iida K; Nakayama N; Otuski Y; Kobayashi H; Nakayama S; Miyazaki K
    Hum Pathol; 2012 Apr; 43(4):506-19. PubMed ID: 21889186
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerated hyperfractionated radiotherapy for locally advanced cervix cancer.
    MacLeod C; Bernshaw D; Leung S; Narayan K; Firth I
    Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):519-24. PubMed ID: 10348280
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Detection of epidermal growth factor receptor mutations in non-small-cell lung carcinoma by direct sequencing and correlations with clinicopathological characteristics and sample types].
    Sun MH; Yang F; Shen L; Zhang L; Chen Y; Cai X; Zhu XL; Zhou XY
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):655-9. PubMed ID: 22321541
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regional differences in gallbladder cancer pathogenesis: Insights from a multi-institutional comparison of tumor mutations.
    Narayan RR; Creasy JM; Goldman DA; Gönen M; Kandoth C; Kundra R; Solit DB; Askan G; Klimstra DS; Basturk O; Allen PJ; Balachandran VP; D'Angelica MI; DeMatteo RP; Drebin JA; Kingham TP; Simpson AL; Abou-Alfa GK; Harding JJ; O'Reilly EM; Butte JM; Matsuyama R; Endo I; Jarnagin WR
    Cancer; 2019 Feb; 125(4):575-585. PubMed ID: 30427539
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Detection of Known and Novel FGFR Fusions in Non-Small Cell Lung Cancer by Comprehensive Genomic Profiling.
    Qin A; Johnson A; Ross JS; Miller VA; Ali SM; Schrock AB; Gadgeel SM
    J Thorac Oncol; 2019 Jan; 14(1):54-62. PubMed ID: 30267839
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-dose-rate californium-252 neutron intracavitary afterloading radiotherapy combined with conformal radiotherapy for treatment of cervical cancer.
    Zhang M; Xu HD; Pan SD; Lin S; Yue JH; Liu JR
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(3):966-71. PubMed ID: 22138462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Undetected human papillomavirus DNA and uterine cervical carcinoma: Association with cancer recurrence.
    Okuma K; Yamashita H; Yokoyama T; Nakagawa K; Kawana K
    Strahlenther Onkol; 2016 Jan; 192(1):55-62. PubMed ID: 26481139
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FGFR1/3 tyrosine kinase fusions define a unique molecular subtype of non-small cell lung cancer.
    Wang R; Wang L; Li Y; Hu H; Shen L; Shen X; Pan Y; Ye T; Zhang Y; Luo X; Zhang Y; Pan B; Li B; Li H; Zhang J; Pao W; Ji H; Sun Y; Chen H
    Clin Cancer Res; 2014 Aug; 20(15):4107-14. PubMed ID: 24850843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Operable Stages IB and II cervical carcinomas: a retrospective study comparing preoperative uterovaginal brachytherapy and postoperative radiotherapy.
    Atlan D; Touboul E; Deniaud-Alexandre E; Lefranc JP; Antoine JM; Jannet D; Lhuillier P; Uzan M; Huart J; Genestie C; Antoine M; Jamali M; Ganansia V; Milliez J; Uzan S; Blondon J
    Int J Radiat Oncol Biol Phys; 2002 Nov; 54(3):780-93. PubMed ID: 12377330
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of post-radiation biopsies on development of fistulae in patients with cervical cancer.
    Feddock J; Randall M; Kudrimoti M; Baldwin L; Shah P; Weiss H; Desimone C
    Gynecol Oncol; 2014 May; 133(2):263-7. PubMed ID: 24525114
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hotspot Mutations Detectable by Next-generation Sequencing in Exhaled Breath Condensates from Patients with Lung Cancer.
    Youssef O; Knuuttila A; Piirilä P; Böhling T; Sarhadi V; Knuutila S
    Anticancer Res; 2018 Oct; 38(10):5627-5634. PubMed ID: 30275180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Residual disease in the uterus after preoperative radiotherapy and hysterectomy in stage IB cervical carcinoma.
    Moyses HM; Morrow CP; Muderspach LI; Roman LD; Vasilev SA; Petrovich Z; Groshen SL; Klement V
    Am J Clin Oncol; 1996 Oct; 19(5):433-8. PubMed ID: 8823468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative evaluation of hypofractionated radiotherapy and conventional fractionated radiotherapy in the management of carcinoma of the cervix in Ibadan, Nigeria.
    Campbell OB; Akinlade IB; Arowojolu A; Babarinsa IA; Agwimah RI; Adewole IF
    Afr J Med Med Sci; 2000; 29(3-4):253-8. PubMed ID: 11714001
    [TBL] [Abstract][Full Text] [Related]  

  • 40. External Beam Radiation Therapy and Brachytherapy for Cervical Cancer: The Experience of the National Centre for Radiotherapy in Accra, Ghana.
    Vulpe H; Asamoah FA; Maganti M; Vanderpuye V; Fyles A; Yarney J
    Int J Radiat Oncol Biol Phys; 2018 Apr; 100(5):1246-1253. PubMed ID: 29395628
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.